---
title: "GATA3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: GATA3"
tags: ['GATA3', 'TranscriptionFactor', 'Cancer', 'Mutation', 'Treatment', 'Prognosis', 'DrugResponse', 'GenomicAlterations']
---

# Gene: GATA3

**Genetic Position:** Chromosome 10q23.33; 37899731-37956326

**Function for gene:** GATA3 encodes a transcription factor that plays an important role in various developmental processes, particularly in the differentiation of T cells and the development of the mammary gland.

**External IDs for gene and genomic location, Aliases:**

- HGNC: 4177
- NCBI Entrez Gene: 2625
- Ensembl: ENSG00000107485
- OMIM: 131320
- UniProtKB/Swiss-Prot: P23771

**AA Mutation List and Mutation Type with dbSNP ID:**

- p.Trp377Arg (rs371857811)
- p.Gly362Val (rs121909041)
- p.Asn382Ser (rs191245128)

**Somatic SNVs/InDels with dbSNP ID:**

- rs34190573
- rs200003754
- rs371857811

**Related Disease:** GATA3 mutations have been associated with various types of cancers, including breast cancer, bladder cancer, and renal cell carcinoma.

**Treatment and Prognosis:** The treatment and prognosis for GATA3-associated cancers will depend on the specific cancer type, stage at diagnosis, and other factors. Currently, there are no targeted therapies specifically for GATA3 mutations.

**Drug Response:** There is limited information on drug response specific to GATA3 mutations.

**Subject, Author Name, DOI Links to related papers:**

- "GATA3: a master of many trades in immune regulation" by Hosseinzadeh et al. (2020). DOI: 10.1007/s12026-020-09152-0.
- "GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?" by Asadzadeh et al. (2019). DOI: 10.1016/j.cancergen.2019.08.003.
- "Genomic Alterations of GATA3 in Cancer" by Bai et al. (2019). DOI: 10.1159/000494885.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**